Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Campos, Jeremy
267  Ergebnisse:
Personensuche X
?
1

Broadly potent anti-SARS-CoV-2 antibody shares 93% of epito..:

Fenwick, Craig ; Turelli, Priscilla ; Duhoo, Yoan...
Journal of Infection.  87 (2023)  6 - p. 524-537 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 ..:

Fenwick, Craig ; Turelli, Priscilla ; Ni, Dongchun...
Nature Microbiology.  7 (2022)  9 - p. 1376-1389 , 2022
Link: https://doi.org/10.1038/..
 
?
3

A high-throughput cell- and virus-free assay shows reduced ..:

Fenwick, Craig ; Turelli, Priscilla ; Pellaton, Céline...
Science Translational Medicine.  13 (2021)  605 - p. , 2021
Link: https://doi.org/10.1126/..
 
?
4

A highly potent antibody effective against SARS-CoV-2 varia..:

Fenwick, Craig ; Turelli, Priscilla ; Perez, Laurent...
Cell Reports.  37 (2021)  2 - p. 109814 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody R..:

Fenwick, Craig ; Croxatto, Antony ; Coste, Alix T....
Journal of Virology.  95 (2021)  3 - p. , 2021
Link: https://doi.org/10.1128/..
 
?
6

Nucleotide based covalent inhibitors of KRas can only be ef..:

Müller, Matthias P. ; Jeganathan, Sadasivam ; Heidrich, Angelika..
Scientific Reports.  7 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
?
7

bMERB domains are bivalent Rab8 family effectors evolved by..:

Rai, Amrita ; Oprisko, Anastasia ; Campos, Jeremy...
eLife.  5 (2016)  - p. , 2016
Link: https://doi.org/10.7554/..
 
?
8

Broadly potent anti-SARS-CoV-2 antibody shares 93% of epito..:

Fenwick, Craig ; Turelli, Priscilla ; Duhoo, Yoan...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jinf.2023.10.008.  , 2023
Link: https://hal.u-pec.fr/hal..
 
?
9

Broadly potent anti-SARS-CoV-2 antibody shares 93% of epito..:

Fenwick, Craig ; Turelli, Priscilla ; Duhoo, Yoan...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jinf.2023.10.008.  , 2023
Link: https://hal.u-pec.fr/hal..
 
?
10

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 ..:

Fenwick, Craig ; Turelli, Priscilla ; Ni, Dongchun...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41564-022-01198-6.  , 2022
Link: https://hal.u-pec.fr/hal..
 
?
11

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 ..:

Fenwick, Craig ; Turelli, Priscilla ; Ni, Dongchun...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41564-022-01198-6.  , 2022
Link: https://hal.u-pec.fr/hal..
 
?
12

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 ..:

Fenwick, Craig ; Turelli, Priscilla ; Ni, Dongchun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418005/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody R..:

Fenwick, Craig ; Croxatto, Antony ; Coste, Alix T...
0022-538X.  , 2021
Link: https://dspace.library.u..
 
?
14

Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody R..:

Fenwick, Craig ; Croxatto, Antony ; Coste, Alix T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925109/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

A highly potent antibody effective against SARS-CoV-2 varia..:

Fenwick, Craig ; Turelli, Priscilla ; Perez, Laurent...
https://boris.unibe.ch/160703/.  , 2021
Link: https://boris.unibe.ch/1..
 
1-15